XHKG0609
Market cap128mUSD
Dec 23, Last price
1.14HKD
1D
-1.72%
1Q
-0.87%
Jan 2017
-42.13%
IPO
79.53%
Name
Tiande Chemical Holdings Ltd
Chart & Performance
Profile
Tiande Chemical Holdings Limited, an investment holding company, engages in the research, development, manufacture, sale, and distribution of fine chemical products in the People's Republic of China, India, the United States, Taiwan, the United Kingdom, and internationally. Its principal products include sodium cyanide, cyanoacetic acid and cyanoacetates, malonates, diethyl ethoxymethylenemalonate, EDTA acids and salts, mono chloroacetic acid and derivatives, ethanol, tert-butanol, cyanoacrylate monomers, and related by-products. The company also engages in the research and development, manufacture, and sale of medical instrument products; and manufacture and sale of adhesive products. Its products are used in synthesis of pharmaceutical products, pesticides, adhesive products, sealants, essences, aromatics, etc. The company was founded in 1997 and is headquartered in Weifang, the People's Republic of China. Tiande Chemical Holdings Limited is a subsidiary of Cheerhill Group Limited.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 2,080,285 -40.91% | 3,520,608 36.21% | 2,584,731 90.14% | |||||||
Cost of revenue | 1,812,589 | 2,334,017 | 2,108,682 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 267,696 | 1,186,591 | 476,049 | |||||||
NOPBT Margin | 12.87% | 33.70% | 18.42% | |||||||
Operating Taxes | 66,627 | 326,964 | 143,806 | |||||||
Tax Rate | 24.89% | 27.55% | 30.21% | |||||||
NOPAT | 201,069 | 859,627 | 332,243 | |||||||
Net income | 211,071 -75.76% | 870,924 129.40% | 379,647 300.38% | |||||||
Dividends | (186,646) | (243,290) | (21,423) | |||||||
Dividend yield | 14.53% | 12.81% | 1.89% | |||||||
Proceeds from repurchase of equity | 18,055 | |||||||||
BB yield | -0.95% | |||||||||
Debt | ||||||||||
Debt current | 45,724 | 154,760 | ||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | (615,063) | (1,671,508) | (1,221,646) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 649,233 | 854,842 | 274,331 | |||||||
CAPEX | (318,469) | (262,102) | (213,472) | |||||||
Cash from investing activities | (543,418) | (469,451) | (84,390) | |||||||
Cash from financing activities | (232,546) | (337,125) | (88,769) | |||||||
FCF | 197,742 | 529,328 | 138,051 | |||||||
Balance | ||||||||||
Cash | 615,063 | 492,130 | 226,349 | |||||||
Long term investments | 1,225,102 | 1,150,057 | ||||||||
Excess cash | 511,049 | 1,541,202 | 1,247,169 | |||||||
Stockholders' equity | 2,419,299 | 2,365,885 | 1,639,988 | |||||||
Invested Capital | 2,046,527 | 937,387 | 556,023 | |||||||
ROIC | 13.48% | 115.12% | 67.81% | |||||||
ROCE | 10.28% | 46.97% | 26.13% | |||||||
EV | ||||||||||
Common stock shares outstanding | 873,606 | 867,510 | 851,954 | |||||||
Price | 1.47 -32.88% | 2.19 64.66% | 1.33 104.62% | |||||||
Market cap | 1,284,201 -32.41% | 1,899,847 67.67% | 1,133,099 104.62% | |||||||
EV | 783,797 | 322,680 | (80,795) | |||||||
EBITDA | 405,855 | 1,315,806 | 601,413 | |||||||
EV/EBITDA | 1.93 | 0.25 | ||||||||
Interest | 176 | 2,767 | 6,450 | |||||||
Interest/NOPBT | 0.07% | 0.23% | 1.35% |